Guangzhou Pharma Hopes To Revitalize TCM Industry With Genome Project
This article was originally published in PharmAsia News
Many experts view the sequencing of the first medicinal plant genome as an indication that the genomic era will revitalize R&D in the Chinese medicine industry
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.